Randomized phase II trial of high-dose 4'-epi-doxorubicin+ cyclophosphamide versus high-dose 4'-epi-doxorubicin+ cisplatin in previously untreated patients with …

E Kanitz, K Kolaric, J Jassem, Z Mechl, M Pawlicki… - Oncology, 1992 - karger.com
One hundred and eleven previously untreated patients with extensive small cell lung cancer
were included in a prospective randomized study with the aim to assess the efficacy and …
被引用次数：12 相关文章

Randomized Phase II Trial of High-Dose 4'-Epi-Doxorubicin+ Cyclophosphamide versus High-Dose 4'-Epi-Doxorubicin+ Cisplatin in Previously Untreated Patients …

E Kánitz, K Kolaric, J Jassem, Z Mechl, M Pawlicki… - Oncology, 1992 - karger.com
One hundred and eleven previously untreated patients with extensive small cell lung cancer
were included in a prospective randomized study with the aim to assess the efficacy and …

[引用][C] Randomized phase II trial of high-dose 4'-epi-doxorubicin+ cyclophosphamide versus high-dose 4'-epi-doxorubicin+ cisplatin in previously untreated patients …

E KANITZ, K KOLARIC, S ECKHARDT, J JASSEM… - …, 1992 - pascal-francis.inist.fr
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose
4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung …

Randomized phase II trial of high-dose 4'-epi-doxorubicin+ cyclophosphamide versus high-dose 4'-epi-doxorubicin+ cisplatin in previously untreated patients with …

E Kánitz, K Kolaric, J Jassem, Z Mechl, M Pawlicki… - Oncology, 1992 - europepmc.org
One hundred and eleven previously untreated patients with extensive small cell lung cancer
were included in a prospective randomized study with the aim to assess the efficacy and …

Randomized phase II trial of high-dose 4'-epi-doxorubicin+ cyclophosphamide versus high-dose 4'-epi-doxorubicin+ cisplatin in previously untreated patients with …

E Kánitz, K Kolaric, J Jassem, Z Mechl… - …, 1992 - pubmed.ncbi.nlm.nih.gov
One hundred and eleven previously untreated patients with extensive small cell lung cancer
were included in a prospective randomized study with the aim to assess the efficacy and …

[引用][C] Randomized phase II trial of high-dose 4'-epi-doxorubicin+ cyclophosphamide versus high-dose 4'-epi-doxorubicin+ cisplatin in previously untreated patients …

E KANITZ, K KOLARIC, J JASSEM, Z MECHL… - Oncology, 1992 - Karger